Related Experiment Video

Updated: Jun 5, 2026

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
04:56

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Published on: December 30, 2025

Proteasome inhibitors induce p53-independent apoptosis in human cancer cells

Bulbul Pandit1, Andrei L Gartel

  • 1Department of Medicine, University of Illinois at Chicago, Chicago, Illinois, USA.

The American Journal of Pathology
|January 13, 2011
PubMed

Insights

Proteasome inhibitors induce cancer cell death independently of the tumor suppressor p53. This study clarifies that proteasome inhibitors trigger apoptosis and inhibit cancer growth regardless of p53 status.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Proteasome inhibitors are vital cancer therapeutics, yet their precise mechanisms, particularly the role of the tumor suppressor p53, remain incompletely understood.
  • The involvement of p53 in proteasome inhibitor-induced apoptosis is a subject of ongoing debate within cancer research.

Purpose of the Study:

  • To elucidate the role of p53 in apoptosis induced by proteasome inhibitors.
  • To investigate the differential effects of various proteasome inhibitors on cancer cell lines with varying p53 genetic status.

Main Methods:

  • Utilized isogenic human cancer cell lines differing in p53 status to assess apoptosis induction.
  • Examined the expression of proapoptotic proteins Noxa and Puma following treatment with proteasome inhibitors.
  • Evaluated the impact of proteasome inhibitors on cancer cell growth across different p53 backgrounds.

Main Results:

  • Proteasome inhibitors (MG132, bortezomib, thiostrepton) induced p53-independent apoptosis.
  • Apoptosis correlated with p53-independent induction of Noxa, but not Puma.
  • Cancer cell growth inhibition by these drugs was also independent of p53 status.
  • Thiostrepton demonstrated enhanced apoptosis in p53-knockdown cells compared to wild-type p53 cells.

Conclusions:

  • Proteasome inhibitors generally induce apoptosis in human cancer cells through a p53-independent pathway.
  • The findings highlight a consistent mechanism of action for proteasome inhibitors irrespective of p53 functionality.
  • These results have implications for the therapeutic application of proteasome inhibitors in diverse cancer types.

More Related Videos

Yeast As a Chassis for Developing Functional Assays to Study Human P5314:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

Cell Death Associated with Abnormal Mitosis Observed by Confocal Imaging in Live Cancer Cells15:53

Cell Death Associated with Abnormal Mitosis Observed by Confocal Imaging in Live Cancer Cells

Published on: August 21, 2013

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...